Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma
出版年份 2019 全文链接
标题
Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma
作者
关键词
-
出版物
JOURNAL OF CLINICAL INVESTIGATION
Volume -, Issue -, Pages -
出版商
American Society for Clinical Investigation
发表日期
2019-02-01
DOI
10.1172/jci98747
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly
- (2018) Niraj Shenoy et al. CANCER CELL
- Drugs with anti-oxidant properties can interfere with cell viability measurements by assays that rely on the reducing property of viable cells
- (2017) Niraj Shenoy et al. LABORATORY INVESTIGATION
- Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells
- (2017) N Shenoy et al. Blood Cancer Journal
- Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective
- (2016) N. Shenoy et al. ANNALS OF ONCOLOGY
- Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies
- (2016) Enrico Munari et al. PLoS One
- Hypoxia-Mediated Increases in l -2-hydroxyglutarate Coordinate the Metabolic Response to Reductive Stress
- (2015) William M. Oldham et al. Cell Metabolism
- Loss ofTET2in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis
- (2015) Kasper D. Rasmussen et al. GENES & DEVELOPMENT
- Role of DNA methylation in renal cell carcinoma
- (2015) Niraj Shenoy et al. Journal of Hematology & Oncology
- Characterization of acute myeloid leukemia based on levels of global hydroxymethylation
- (2014) L. I. Kroeze et al. BLOOD
- Kidney Cancer Is Characterized by Aberrant Methylation of Tissue-Specific Enhancers That Are Prognostic for Overall Survival
- (2014) C. Y. Hu et al. CLINICAL CANCER RESEARCH
- Pharmacokinetic modeling of ascorbate diffusion through normal and tumor tissue
- (2014) Caroline Kuiper et al. FREE RADICAL BIOLOGY AND MEDICINE
- Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12
- (2014) Michael Crump et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
- (2014) Y. Ma et al. Science Translational Medicine
- L-2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer
- (2014) E.-H. Shim et al. Cancer Discovery
- Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
- (2013) Christopher M. Stephenson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Ascorbic Acid Enhances Tet-Mediated 5-Methylcytosine Oxidation and Promotes DNA Demethylation in Mammals
- (2013) Ruichuan Yin et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells
- (2013) Kathryn Blaschke et al. NATURE
- Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer
- (2013) Sanchari Bhattacharyya et al. NUCLEIC ACIDS RESEARCH
- TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group
- (2012) Verena I. Gaidzik et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
- (2012) Daniel A. Monti et al. PLoS One
- Quantitative Sequencing of 5-Methylcytosine and 5-Hydroxymethylcytosine at Single-Base Resolution
- (2012) M. J. Booth et al. SCIENCE
- Angiogenic ability of metastatic squamous carcinoma in the cervical lymph nodes from unknown primary tumours
- (2011) B. Agarwal et al. JOURNAL OF CLINICAL PATHOLOGY
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- Wilms Tumor in a Child with L-2-hydroxyglutaric Aciduria
- (2010) Robert E. Rogers et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- Isocitrate dehydrogenase 1/2 mutational analyses and 2-hydroxyglutarate measurements in Wilms tumors
- (2010) Dinesh Rakheja et al. PEDIATRIC BLOOD & CANCER
- IDH mutations in glioma and acute myeloid leukemia
- (2010) Lenny Dang et al. TRENDS IN MOLECULAR MEDICINE
- Optimized design and data analysis of tag-based cytosine methylation assays
- (2010) Masako Suzuki et al. GENOME BIOLOGY
- Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects
- (2009) Julien Verrax et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
- (2008) L. J. Hoffer et al. ANNALS OF ONCOLOGY
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice
- (2008) Q. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started